Status:
COMPLETED
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study will determine the appropriate dose and frequency of administration of sc Mircera maintenance therapy in dialysis patients with chronic renal anemia who were previously receiving sc epoetin...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- chronic renal anemia;
- on dialysis (hemodialysis or peritoneal dialysis) therapy for at least 3 months;
- receiving sc epoetin alfa or beta for at least 3 months prior to the run-in period.
Exclusion
- women who are pregnant, breastfeeding or using unreliable birth control methods;
- use of any investigational drug within 30 days preceding the run-in phase, or during the run-in or study treatment period.
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT00364832
Start Date
October 1 2001
End Date
July 1 2005
Last Update
December 20 2016
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles, California, United States, 90073
2
San Jose, California, United States, 95116-1906
3
Boston, Massachusetts, United States, 02130
4
Cleveland, Ohio, United States, 44106